L12: Alcoholic liver disease Flashcards

1
Q

Blood flow in the liver

A

Hepatic artery→ oxygenated blood to liver→ hepatic veins→ inferior vena cava

GI tract and spleen→ Portal vein→ products of digestion to liver→ processes nutrients and filters toxins→ hepatic veins→ inferior vena cava

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stages of Alcoholic liver disease

A

Not distinct stages, multiple stages may be present at once

  1. Fatty Liver (Simple Steatosis) (present in most drinkers >60g/day)
  2. Alcoholic Hepatitis
  3. Chronic Hepatitis with fibrosis or cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for Alcoholic liver disease

A

Women→ 2x as sensitive to ETOH hepatotoxicity & develop more severe ALD at lower doses with shorter duration
African American>Hispanic> Caucasian males
Obesity→ limit to 1 drink a day
Genetic Factors→ alcoholism & ALD
Hepatitis C+ alcohol→ more rapid progression→ limit to 1 drink a day
ALD + smoking→ increased risk of hepatocellular cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progression of cirrhosis/fibrosis/HCC

A
Normal liver + chronic alcohol use 
Steatosis
Steatohepatitis
Fibrosis
Cirrhosis
Hepatocellular Carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How much do you have to drink to get alcoholic liver disease?

A

Risk of developing cirrhosis increases with daily consumption:

Men >3 drinks/day for >5 years
Women >2 drinks/day for >5 years

Risk increased with >30 g/day

Amount of alcohol ingested→ most important risk factor

+/- Type of alcohol→ Beer or spirits > wine

Pattern of Drinking→ drinking outside meal times increases risk

Relationship to quantity is not completely linear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fatty liver pathophysiology

A

Increased mobilization of free fatty acid from peripheral stores
Increased triglyceride formation
Decreased fatty acid oxidation
Reduced lipoprotein release by liver
Accumulation of fat (small or large droplets) in the cytoplasm of liver cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fatty liver presentation

A

Asymptomatic +/- hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fatty liver management

A

Often completely reversible with 4-6 weeks of abstinence

May progress to fibrosis or cirrhosis, especially with continued drinking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inflammation of liver characterized by necrosis (death) and fibrotic scarring
Mild (few symptoms) to severe presentation with advanced liver disease (cirrhosis in 50%)
High risk of progressive liver injury with cirrhosis developing in 50%

A

Alcoholic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alcoholic hepatitis presentation

A
Asymptomatic to mild to severe
Severe→ marked impairment of liver function: 
Fever
Leukocytosis
Hepatic encephalopathy
Spider angiomas
*Jaundice*
Hepatosplenomegaly with liver tenderness
Edema (scrotal or LE)
*Ascites*
*Variceal bleeding*
Oliguria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alcoholic hepatitis labs

A
CBC – leukocytosis with left shift, Macrocytosis (MCV elevated), Thrombocytopenia
AST/ALT ratio >2→ classic
AST <500 IU/L. (2-6X ULN) 
ALT < 200 IU/L
ALP→ mildly elevated
Bilirubin→ Elevated, Direct>Indirect
PT/ INR→ Elevated
Albumin→ low
Hyponatremia
Hypokalemia
GTP→ Elevated secondary to ETOH use
Folate→ Low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alcoholic hepatitis histology

A

Clumps of intracellular material→ Alcoholic hyaline (Mallory bodies)

Fatty infiltration

  • Neutrophil infiltration* around clusters of necrotic hepatocytes
  • Fibrosis* around hepatic venules→ precursor to cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alcoholic hepatitis diagnosis

A

Liver biopsy is required for diagnosis
* When there is an unclear history of alcohol use and elevated liver tests
* Confounded by other risk factors for liver disease and considering
pharmacotherapy with steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alcoholic hepatitis management

A

Nutritional Assessment + therapy
Do not limit protein intake
Sodium restricted diet (<2000 mg/day)
Address vitamin deficiencies/malnutrition
Discontinue non-selective beta blockers (increase risk of AKI)
Treatment of Alcohol Withdrawal
Infection Surveillance
Fluid overload management→ Diuretics→ Lasix, Spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mallory bodies

A

Seen on histology of alcoholic hepatitis:

Clumps of intracellular material→ Alcoholic hyaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Folate deficiency + elevated LFTs

A

Alcoholic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Discontinuing all alcohol in alcoholic hepatitis

A
Improve outcome
Improve histological features
Reduce portal pressure/complications (ascites, variceal bleeding)
Decrease progression to cirrhosis
Improve survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Severe alcoholic hepatitis is defined as

A

MDF >32 or MELD >20

These people get a 7 day trial of steroids using MDF for starting steroids, Lillie score for discontinuing steroids

They can get a liver transplant if they meet specific criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk assessment calculators

A

Risk assessment calculators:
Model of End Stage Liver Disease (MELD score) → bilirubin, creatinine, INR→
> 20→ Severe, poor prognosis

Maddery (Modified) Discriminant Factor (MDF) → Protein, Protein control, bilirubin→ > 32→ Severe, Poor Prognosis (50% mortality 1 month) → steroids beneficial

Lillie Score → bilirubin, albumin, creatinine, protime at day 0→ bilirubin day 7→ Determine if steroids should be continue

If a patient is has a high mortality risk, they are hospitalized (MELD >20?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hepatocellular dysfunction + portosystemic shunting→ Failure of the liver to detoxify noxious agents of gut origin→ impaired brain function
Ammonia is the best known neurotoxin

A

Hepatic encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hepatic encephalopathy presentation

A

EEG changes

Asterixis: flapping tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Grading of hepatic encephalopathy

A

Grade I→ Subclinical or Covert Encephalopathy→ Changes in behavior, mild confusion, slurred speech,
disordered sleep pattern
Grade II→ Lethargy, moderate confusion
Grade III→ Marked confusion (stupor), incoherent speech, sleeping but can arouse.
Grade IV→ Coma, unresponsive to pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Stroop test

A

Brief cognitive screening tools, which do not require psychological expertise in administration interpretation

Evaluate psychomotor speed and cognitive flexibility→ diagnose minimal hepatic encephalopathy (very sensitive + specific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hepatic encephalopathy treatment

A

Treat any precipitating factors: GI bleeding, infection, sedating
medications, electrolyte abnormalities, constipation, renal failure

Lactulose, Rifaximin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lactulose

A

ammonia reducer

acute overt hepatic encephalopathy and secondary
prophylactic therapy for an indefinite period of time

26
Q

Widespread destruction and regeneration of liver tissue→ marked increase in fibrotic connective tissue, scarring→ impairment of liver function
Regenerated liver tissue forms nodules→ permanent alters the structure
Continued necrosis & fibrosis→ progressive deterioration
Inflammatory cell infiltration common

A

Chronic Hepatitis with Fibrosis or Cirrhosis

27
Q

Compensated Chronic Hepatitis with Fibrosis or Cirrhosis

A

Portal Pressure is <10.
Median Survival ~ 12 years
Splenomegaly→ thrombocytopenia, leukopenia, anemia, AST elevation

28
Q

Decompensated Chronic Hepatitis with Fibrosis or Cirrhosis

A

Increased Portal Pressure. Decreased
Liver Function.
Median Survival <2 years
Microvasculature severely distorted→ hepatic blood flow bypasses vascular scars→ portal hypertension, portosystemic shunting, impaired liver function

29
Q

Complications of Chronic Hepatitis with Fibrosis or Cirrhosis

A

Portal hypertension
Spontaneous bacterial peritonitis
Hepatic encephalopathy
Hepatorenal syndrome

30
Q

Chronic Hepatitis presentation

A
Cirrhosis with increased portal hypertension (decompensated) 
Ascites
Esophageal and rectal varices
Splenomegaly→ leukopenia, thrombocytopenia
Dilated abdominal veins
Fatigue, anorexia
Weakness
Palmar erythema
Parotid enlargement
Dupuytren’s contracture
Palmar erythema
Jaundice
Gynecomastia
Testicular atrophy
Spider nevi
Muscle wasting anemia (chronic disease or IDA).
Hepatic encephalopathy
(asterixis)
31
Q

Chronic hepatitis labs

A

Similar to Alcoholic hepatitis
AST elevation
Normal in compensated cirrhosis
Anemia→ Anemia of chronic disease, folate deficiency, suppression of hematopoiesis from ETOH, hemolysis, GI blood loss, or splenomegaly
Coagulation abnormalities→ reduced synthesis of clotting factors
Splenomegaly→ leukopenia, thrombocytopenia

32
Q

Portal hypertension

A

Increased pressure within the portal venous system
+/- 3 sites of obstruction:
1. Prehepatic: portal vein thrombosis (cirrhosis or other)
2. Intrahepatic: cirrhosis
3. Posthepatic: CHF, constrictive pericarditis

33
Q

Pathophysiology of portal htn in chronic hepatitis

A

Increase hydrostatic pressure in peritoneal capillaries→ ascites

Splenomegaly→ anemia, leukopenia, thrombocytopenia→ bleeding

Collateral channels→ caput medusae, esophageal/rectal varices, hemorrhoids

Shunting of ammonia/toxins from intestine to general circulation→ hepatic encephalopathy

34
Q

How to get a liver transplant if you have chronic hepatitis

A

Refer decompensated cirrhosis + MELD >15

Requires 6 months abstinence before can consider for transplant→ AA/Abstinence Program

35
Q

Ascites treatment

A

<2g/d sodium
Lasix, Spironolactone
Fluid restriction ONLY if sodium is <125 mmol/L

36
Q

Refractory ascites treatment

A

Stop beta blocker

Therapeutic Paracentesis→ with 6-8 Albumin per liter drained if > 5-6L (prevent kidney injury)

TIPS→ Transjugular intrahepatic Portosystemic Shunt→ reduces ascites, variceal hemorrhage, quality of life→ no increased survival rate

37
Q

Prophylaxis for variceal bleeding

A

Non-selective beta blocker

HR 55-60 and SBP <90 is goal→ no EGD for surveillance needed

38
Q

How to monitor or band varices

A

EGD

39
Q

Hepatocellular carcinoma surveillance for chronic hepatitis

A

US q 6 months +/- AFP

40
Q

Is (acute) Alcoholic hepatitis reversible?

A

Mild cases with abstinence are reversible.

Recurrent episodes→ irreversible, progressive liver disease, decompensated cirrhosis.

41
Q

Prognosis for alcoholic cirrhosis

A

poor

Continued ETOH→ 4 year survival with a major complication (Refractory Ascites, HRS*) < 20%

42
Q

Hepatorenal syndrome

A

Functional renal failure in setting of decompensated cirrhosis

Type 1→ Rapidly + progressive renal failure with severe multi-organ failure
Median survival < 4 weeks

Type 2→ associated with refractory ascites
Median survival ~ 6 months

43
Q

Hepatorenal syndrome diagnsosi

A

Cirrhosis with Ascites

Absence of shock

Renal Impairment
Rise in Cr of 0.3+ mg/dL in 48 hours
50% increase from baseline in 1 week

No improvement with correction of volume status + albumin* x 2 days
Withdrawal of diuretics
Volume expansion with albumin*

Absence of other causes of AKI
Exclude shock, infection, bleeding, sepsis, fluid losses, use of nephrotoxic drugs, intrinsic renal pathology

44
Q

Hepatorenal syndrome presentation

A

Ascites

Serum creatinine level >1.5 mg/dL

Azotemia → increased BUN

Oliguria→ < 500 ml/d

Hyponatremia (<130)

Hypotension

45
Q

Hepatorenal syndrome prevention

A

Albumin IV if large volume (>5L) paracentesis

Protect against GI bleeding→ EGD

Surveillance or beta blocker use

46
Q

Don’t give _____ to prevent Hepatorenal syndrome

A

NSAIDs or Supplements

47
Q

Spontaneous bacterial peritonitis prophylaxis

A

Previous dx → DS Bactrim daily or Ciprofloxacin 500 mg daily
Variceal bleed x 3-7 days → 3-7 days IV ceftriaxone
Ascetic protein < 1.5 g/dl

48
Q

Benign Lesions usually requiring no further intervention if definitely identified on imaging

A

Cavernous Hemangioma < 4 cm
Focal nodular hyperplasia
Simple cyst < 4 cm and asymptomatic
Focal fatty change/sparing

49
Q

Malignant Lesions requiring appropriate management

A

Metastases
Lymphoma “The Great Masquerader”

Primary Liver neoplasm:

  1. Hepatocellular carcinoma
  2. Cholangiocarcinoma
  3. Rare tumors→ cystadenocarcinoma, angiosarcoma
50
Q

Benign Lesions requiring further investigation and therapy→ refer to GI/hepatology

A

Adenoma→ malignant potential (5%) and increase risk of bleeding
Associated with use of oral contraceptives pills (OCP)
Liver Abscess→ pyogenic, amebic
Inflammatory pseudotumor
Atypical/complex cysts and large symptomatic simple cysts

51
Q

Hepatocellular cancer

A

Third leading cause of cancer
More common→ Africa, China, Japan, SE Asia
High index of suspicion: Cirrhotic patients or patients with
non-cirrhotic Hepatitis B with liver lesion on imaging
M>F

52
Q

Risk for hepatocellular cancer

A

All suspected cirrhotic patients from any liver disease

Platelet count <150, 000

US Elastography w/ kPA > 20

Chronic Hepatitis B (non-cirrhotic)

Asian females >50

Asian males > 40

FH + Hep B infection

African descent >20

Screen with US q 6 months +/- AFP

53
Q

Hepatocellular cancer presentation

A

Cachexia
Weakness
Weight loss
Sudden appearance of ascites

54
Q

Hepatocellular cancer diagnosis

A

Elevated Alkaline Phosphatase
Elevated Alpha-fetoprotein
Triphasic CT scan → non-diagnostic→ Triphasic MRI with gadolinium
Liver Biopsy is DIAGNOSTIC→ risk of tumor seeding→ not needed if imaging + elevated AFP

55
Q

Hepatocellular cancer management

A

Resection rarely feasible due to background cirrhosis
Non-cirrhotic HBV often resectable even if large tumor

Cirrhotic HCC when bilirubin is normal and no portal HTN

Liver Transplant→ early stage cancer
• 1 lesion up to 5 cm or 3 lesions up to 3 cm AND no vascular invasion or distant spread

RFA for small tumors ( ~ 3cm) if non-operative

TACE/TARE or XRT→ large tumors if sufficient hepatic reserve

Advanced stage→ Systemic Therapy for distant spread

End Stage→ Symptomatic

56
Q

Hepatocellular carcinoma arises from

A

Parenchymal cells

57
Q

Radiofrequency Ablation (RFA)

A

for small tumors ( ~ 3cm) if non-operative

58
Q

Transarterial Chemoembolization (TACE)

A

large tumors if sufficient hepatic reserve

59
Q

Transarterial Radioembolization (TARE)

A

large tumors if sufficient hepatic reserve

60
Q

Radiation/ Radiotherapy (XRT)

A

large tumors if sufficient hepatic reserve